Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial - Kim, Dong-Wan; Thomas, Michael (The lancet. Oncology, 2016)
Gesehen am 11.12.2019